305 related articles for article (PubMed ID: 16854081)
1. Design, synthesis, and evaluation of proline and pyrrolidine based melanocortin receptor agonists. A conformationally restricted dipeptide mimic approach.
Tian X; Field TB; Switzer AG; Mazur AW; Ebetino FH; Wos JA; Berberich SM; Jayasinghe LR; Obringer CM; Dowty ME; Pinney BB; Farmer JA; Crossdoersen D; Sheldon RJ
J Med Chem; 2006 Jul; 49(15):4745-61. PubMed ID: 16854081
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.
Kitbunnadaj R; Zuiderveld OP; De Esch IJ; Vollinga RC; Bakker R; Lutz M; Spek AL; Cavoy E; Deltent MF; Menge WM; Timmerman H; Leurs R
J Med Chem; 2003 Dec; 46(25):5445-57. PubMed ID: 14640553
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of 3-arylpyrrolidine-2-carboxamide derivatives as melanocortin-4 receptor ligands.
Tran JA; Tucci FC; Arellano M; Jiang W; Chen CW; Marinkovic D; Fleck BA; Wen J; Foster AC; Chen C
Bioorg Med Chem Lett; 2008 Mar; 18(6):1931-8. PubMed ID: 18294847
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and evaluation of proline based melanocortin receptor ligands.
Tian X; Field T; Mazur AW; Ebetino FH; Wos JA; Crossdoersen D; Pinney BB; Sheldon RJ
Bioorg Med Chem Lett; 2005 Jun; 15(11):2819-23. PubMed ID: 15911261
[TBL] [Abstract][Full Text] [Related]
6. Design of novel melanotropin agonists and antagonists with high potency and selectivity for human melanocortin receptors.
Cai M; Mayorov AV; Ying J; Stankova M; Trivedi D; Cabello C; Hruby VJ
Peptides; 2005 Aug; 26(8):1481-5. PubMed ID: 15876475
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor.
Chen C; Jiang W; Tran JA; Tucci FC; Fleck BA; Markison S; Wen J; Madan A; Hoare SR; Foster AC; Marinkovic D; Chen CW; Arellano M; Saunders J
Bioorg Med Chem Lett; 2008 Jan; 18(1):129-36. PubMed ID: 18032040
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Tic-D-Phe Psi[CH2-CH2] isostere and its use in the development of melanocortin receptor agonists.
Tian X; Chen X; Gan L; Hayes JC; Switzer AG; Solinsky MG; Ebetino FH; Wos JA; Pinney BB; Farmer JA; Crossdoersen D; Sheldon RJ
Bioorg Med Chem Lett; 2006 Mar; 16(6):1721-5. PubMed ID: 16376076
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 4-fluoroproline and 4-fluoropyrrolidine-2-acetic acid derivatives as new GABA uptake inhibitors.
Zhuang W; Zhao X; Zhao G; Guo L; Lian Y; Zhou J; Fang D
Bioorg Med Chem; 2009 Sep; 17(18):6540-6. PubMed ID: 19703775
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor.
Shi Q; Ornstein PL; Briner K; Richardson TI; Arnold MB; Backer RT; Buckmaster JL; Canada EJ; Doecke CW; Hertel LW; Honigschmidt N; Hsiung HM; Husain S; Kuklish SL; Martinelli MJ; Mullaney JT; O'Brien TP; Reinhard MR; Rothhaar R; Shah J; Wu Z; Xie C; Zgombick JM; Fisher MJ
Bioorg Med Chem Lett; 2006 May; 16(9):2341-6. PubMed ID: 16297618
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of pyrrolidine derivatives as potent agonists of the human melanocortin-4 receptor.
Jiang W; Tran JA; Tucci FC; Fleck BA; Hoare SR; Markison S; Wen J; Chen CW; Marinkovic D; Arellano M; Foster AC; Chen C
Bioorg Med Chem Lett; 2007 Dec; 17(23):6546-52. PubMed ID: 17933528
[TBL] [Abstract][Full Text] [Related]
12. Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.
Kazuta Y; Hirano K; Natsume K; Yamada S; Kimura R; Matsumoto S; Furuichi K; Matsuda A; Shuto S
J Med Chem; 2003 May; 46(10):1980-8. PubMed ID: 12723960
[TBL] [Abstract][Full Text] [Related]
13. Locked conformations for proline pyrrolidine ring: synthesis and conformational analysis of cis- and trans-4-tert-butylprolines.
Koskinen AM; Helaja J; Kumpulainen ET; Koivisto J; Mansikkamäki H; Rissanen K
J Org Chem; 2005 Aug; 70(16):6447-53. PubMed ID: 16050708
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor.
Richardson TI; Ornstein PL; Briner K; Fisher MJ; Backer RT; Biggers CK; Clay MP; Emmerson PJ; Hertel LW; Hsiung HM; Husain S; Kahl SD; Lee JA; Lindstrom TD; Martinelli MJ; Mayer JP; Mullaney JT; O'Brien TP; Pawlak JM; Revell KD; Shah J; Zgombick JM; Herr RJ; Melekhov A; Sampson PB; King CH
J Med Chem; 2004 Jan; 47(3):744-55. PubMed ID: 14736255
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of the modified melanocortin peptides responsible for ligand selectivity at the human melanocortin receptors.
Chen M; Georgeson KE; Harmon CM; Haskell-Luevano C; Yang Y
Peptides; 2006 Nov; 27(11):2836-45. PubMed ID: 16730390
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6.
Grieco P; Han G; Weinberg D; Van der Ploeg LH; Hruby VJ
Biochem Biophys Res Commun; 2002 Apr; 292(4):1075-80. PubMed ID: 11944925
[TBL] [Abstract][Full Text] [Related]
17. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
18. Introduction of a cis-prolyl mimic in position 7 of the peptide hormone oxytocin does not result in antagonistic activity.
Wittelsberger A; Patiny L; Slaninova J; Barberis C; Mutter M
J Med Chem; 2005 Oct; 48(21):6553-62. PubMed ID: 16220972
[TBL] [Abstract][Full Text] [Related]
19. Conformationally constrained kappa receptor agonists: stereoselective synthesis and pharmacological evaluation of 6,8-diazabicyclo[3.2.2]nonane derivatives.
Geiger C; Zelenka C; Lehmkuhl K; Schepmann D; Englberger W; Wünsch B
J Med Chem; 2010 May; 53(10):4212-22. PubMed ID: 20441176
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective synthesis and structure-affinity relationships of bicyclic kappa receptor agonists.
Kracht D; Rack E; Schepmann D; Fröhlich R; Wünsch B
Org Biomol Chem; 2010 Jan; 8(1):212-25. PubMed ID: 20024152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
